• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[前列腺癌的临床研究]

[Clinical studies in prostatic carcinoma].

作者信息

Kumanov Kh, Tsvetkov M

出版信息

Khirurgiia (Sofiia). 1993;46(5):6-8.

PMID:7983831
Abstract

Carcinoma of the prostate is a widespread disease posing serious problems, especially when patient in stage T3-T4 are concerned. Proceeding from clinical observations on 269 patients presenting the aforementioned condition, and on the basis of thorough clinical, laboratory and histologic studies, a combined therapeutic approach using cyproterone acetate is adopted, supplemented by orchiectomy in some patients, and transurethral resection in others. After 3-month treatment course, changes in the level of microelements, copper, zinc and iron in particular, are recorded. In some cases the level of prostate specific antigen is lowered. Control of the underlying disease is successfully attained in 72 per cent of the patients.

摘要

前列腺癌是一种广泛存在的疾病,会引发严重问题,尤其是对于处于T3 - T4期的患者。基于对269例患有上述病症患者的临床观察,并在全面的临床、实验室和组织学研究基础上,采用了醋酸环丙孕酮的联合治疗方法,部分患者辅以睾丸切除术,其他患者则进行经尿道切除术。经过3个月的治疗疗程后,记录了微量元素,特别是铜、锌和铁水平的变化。在某些情况下,前列腺特异性抗原水平降低。72%的患者成功实现了对基础疾病的控制。

相似文献

1
[Clinical studies in prostatic carcinoma].[前列腺癌的临床研究]
Khirurgiia (Sofiia). 1993;46(5):6-8.
2
Treatment of locally advanced prostatic carcinoma with LHRH analogues: cytological, DNA-cytophotometrical, and clinical results.
Am J Clin Oncol. 1988;11 Suppl 1:S19-28.
3
[The treatment of prostatic carcinoma with cyproterone acetate].[醋酸环丙孕酮治疗前列腺癌]
Khirurgiia (Sofiia). 1996;49(1):12-5.
4
[Therapy of prostatic cancer with cyproterone acetate].
Wien Klin Wochenschr. 1988 Jan 8;100(1):16-9.
5
Management of metastatic prostatic carcinoma.转移性前列腺癌的管理
Drug Ther Bull. 1986 Nov 3;24(22):85-8.
6
Management of newly diagnosed metastatic carcinoma of the prostate.新诊断前列腺转移性癌的管理
Urol Clin North Am. 1984 May;11(2):283-95.
7
[What is safe in the therapy of advanced prostatic cancer?].[晚期前列腺癌治疗中的安全措施是什么?]
Internist (Berl). 1985 Dec;26(12):765-70.
8
Uncommon course of carcinoma of the prostate after radical prostatectomy and luteinizing hormone-releasing hormone analogue therapy.前列腺癌根治术及促黄体生成素释放激素类似物治疗后的罕见病程
J Urol. 1998 Oct;160(4):1432-3.
9
[Treatment of prostatic cancer].[前列腺癌的治疗]
J Urol (Paris). 1984;90(10):619-48.
10
A comparison between surgical orchidectomy and LH-RH analogue ('Zoladex', ICI 118,630) in the treatment of advanced prostatic carcinoma--a multi-centre clinical study.手术去势与LH-RH类似物(“诺雷德”,ICI 118,630)治疗晚期前列腺癌的多中心临床研究比较
Prog Clin Biol Res. 1988;260:89-100.